- Home
- HRTX vs VLT Comparison
HRTX vs VLT Comparison
Compare HRTX & VLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.33
Company Overview
Basic Information| Metric | HRTX | VLT |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.1M | 57.9M |
| IPO Year | 2007 | 1994 |
Fundamental Metrics
Financial Performance| Metric | HRTX | VLT |
|---|---|---|
| Price | $0.33 | $8.91 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 43.9K |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.26 | $8.70 |
| 52 Week High | $1.58 | $11.31 |
Technical Indicators
Market Signals| Indicator | HRTX | VLT |
|---|---|---|
| Relative Strength Index (RSI) | 50.81 | 41.83 |
| Support Level | $0.28 | $8.70 |
| Resistance Level | $0.34 | $9.18 |
| Average True Range (ATR) | 0.03 | 0.08 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 42.72 | 31.37 |
Price Performance
Historical Comparison HRTX
VLT
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About VLT Invesco High Income Trust II
Invesco High Income Trust II is a diversified, closed-end management investment company. Its investment objective is to provide high current income, while seeking to preserve shareholders' capital through investment in a professionally managed, diversified portfolio of high-income producing fixed-income securities.